首页> 外文期刊>Archives of otolaryngology--head & neck surgery. >The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
【24h】

The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.

机译:分子标志物和肿瘤组织学类型在甲状腺乳头状癌中央淋巴结转移中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To look for genetic mutations that might predict central compartment lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC) using strict criteria for N0 and N1 disease. DESIGN: We identified patients with PTC from our institution's pathology archives. Strict criteria were used for assessing the presence or the absence of central neck LNM. Disease was classified as N0 only if a comprehensive ipsilateral and pretracheal central neck dissection was performed and if pathological analysis revealed no evidence of LNM. Primary tumor samples were analyzed for a panel of known or suspected PTC-associated molecular markers, including BRAF, RET -PTC, KRAS, NRAS, HRAS, PIK3CA, and their variants. SETTING: Academic medical center. PATIENTS: Three hundred eighty-nine patients with PTC. MAIN OUTCOME MEASURE: Molecular mutations in tumors with and without LNM. RESULTS: Of 389 identified cases, 209 fit the inclusion criteria, with 158 classified as node positive (N1) and 51 as node negative (N0). The follicular variant histological type was present in 7 of 158 N1 tumors (4.4%) and 24 of 51 N0 tumors (47.1%) and thus was strongly associated with lack of central neck metastasis in this study (odds ratio, 0.05; 95% CI, 0.02-0.14). Predictive factors for central LNM included extracapsular extension, angiolymphatic invasion, and higher T stage (T3 and T4). The BRAF mutation was more prevalent in the classic PTC histological type than the follicular variant. None of the molecular marker mutations that were analyzed in this study, including the BRAF mutation, predicted LNM in classic PTC. CONCLUSIONS: Positive risk factors for central LNM include male sex, extracapsular extension, angiolymphatic invasion, and advanced T stage. The follicular variant histological type has a significantly lower incidence of central neck metastasis. In contrast to recent studies, the BRAF mutation was not significantly associated with central neck LNM from PTC when using a strict definition of a central neck dissection.
机译:目的:使用严格的N0和N1疾病标准,寻找可预测甲状腺乳头状癌(PTC)中心室淋巴结转移(LNM)的基因突变。设计:我们从我们机构的病理学档案中识别出PTC患者。严格的标准用于评估中央颈部LNM的存在与否。仅当进行了全面的同侧和气管前中央颈部解剖并且病理分析显示没有LNM的证据时,该疾病才被分类为N0。分析原发性肿瘤样品中的一组已知或疑似PTC相关分子标记,包括BRAF,RET -PTC,KRAS,NRAS,HRAS,PIK3CA及其变体。地点:学术医学中心。患者:389例PTC患者。主要观察指标:有或无LNM的肿瘤中的分子突变。结果:在389个确定的病例中,有209个符合纳入标准,其中158个分类为结节阳性(N1),51个分类为结节阴性(N0)。 158个N1肿瘤中有7个(4.4%)和51个N0肿瘤中有24个(47.1%)存在滤泡变体组织学类型,因此在该研究中与缺乏中央颈转移密切相关(比值比为0.05; 95%CI ,0.02-0.14)。中央LNM的预测因素包括囊外扩张,血管淋巴管浸润和较高的T期(T3和T4)。在经典的PTC组织学类型中,BRAF突变比卵泡变体更为普遍。在这项研究中分析的所有分子标记突变(包括BRAF突变)均无法预测经典PTC中的LNM。结论:中央LNM的积极危险因素包括男性,包膜外延伸,血管淋巴管浸润和晚期T期。滤泡变体的组织学类型具有明显较低的中央颈部转移发生率。与最近的研究相反,当使用严格定义的中央颈部解剖时,BRAF突变与PTC的中央颈部LNM没有显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号